Free to Breathe

Free to Breathe is a partnership of lung cancer survivors, advocates, researchers, healthcare professionals, and industry leaders united by a commitment to finding a cure for lung cancer. By funding research with the greatest potential to save lives, increasing the number of lung cancer patients participating in clinical trials, and empowering the lung cancer community, Free to Breathe hopes to double the lung cancer survival rate by 2022.